2004
DOI: 10.1590/s0041-87812004000100008
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary hemorrhage as a manifestation of systemic lupus erythematosus

Abstract: The authors report a case of a 19-year-old woman admitted for the investigation of fever and hemolytic anemia for the previous 2 months. As an inpatient, she had convulsions and sudden loss of consciousness, developing hemoptysis, hypoxia, and respiratory insufficiency. Examination showed pericardial effusions on the echocardiogram and bilateral alveolar condensations on the thoracic radiograph. A hypothetical diagnosis of systemic lupus erythematosus was made, and measurement of the antinuclear factor was req… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2009
2009
2015
2015

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 14 publications
0
6
0
Order By: Relevance
“…the therapeutic protocol for sle-associated DaH is not well defined. early treatment with high-dose intravenous corticosteroids is the mainstay of therapy, but this is not effective for every patient, 9 including the patient described in this report. when the patient was referred for uC-msCt, her condition was so critical that treatment with cyclophosphamide, which often exerts a slow and moderate level of immunosuppression, was inade quate.…”
Section: Treatmentmentioning
confidence: 87%
“…the therapeutic protocol for sle-associated DaH is not well defined. early treatment with high-dose intravenous corticosteroids is the mainstay of therapy, but this is not effective for every patient, 9 including the patient described in this report. when the patient was referred for uC-msCt, her condition was so critical that treatment with cyclophosphamide, which often exerts a slow and moderate level of immunosuppression, was inade quate.…”
Section: Treatmentmentioning
confidence: 87%
“… First, patients with connective tissue diseases, such as systemic sclerosis [5–12] or lupus erythematosus [13–17], in whom the risk of gastrointestinal bleeding or pulmonary bleeding may be higher compared with IPAH patients [2]. Second, patients with PAH related to congenital heart disease (CHD) may be at some increased risk of haemoptysis [18,19].…”
Section: Introductionmentioning
confidence: 99%
“…• First, patients with connective tissue diseases, such as systemic sclerosis [5][6][7][8][9][10][11][12] or lupus erythematosus [13][14][15][16][17], in whom the risk of gastrointestinal bleeding or pulmonary bleeding may be higher compared with IPAH patients [2].…”
Section: Introduction Thrombosis Vs Increased Bleeding Risk In Pulmomentioning
confidence: 99%
“…Depending on the aetiology of the haemorrhage, there may be associated pulmonary capillaritis, neutrophil infiltration, interalveolar septal capillary thrombi, and even capillary wall necrosis 1. Some of the disorders that can cause this condition include Churg-Strauss syndrome,2 Wegener’s granulomatosis,3 systemic lupus erythematosus,4 Goodpasture’s syndrome,5 acute post-streptococcal glomerulonephritis,6 and potentially any pulmonary renal syndrome 7. DAH can also be idiopathic without any inflammatory process.…”
Section: Discussionmentioning
confidence: 99%